David V. Smith

Biography

 David V. Smith joined in March 2016. Mr. Smith currently serves as Chief Operating Officer of IntegenX, a privately held company focused on rapid DNA identification technology, where he has been instrumental in refocusing the business, implementing operational controls and raising capital. Mr. Smith previously was Executive Vice President and Chief Financial Officer of Thoratec Corporation, a leader in developing therapies for advanced heart failure, where he led actions to improve financial controls, analytics and processes. Prior to that Mr. Smith held various financial management positions with Chiron Corporation, a multi-billion dollar biotechnology company, advancing to Vice President and Chief Financial Officer. Mr. Smith also served as Vice President, Finance and Chief Financial Officer of Anergen, Inc. and held various financial management positions with Genentech, Inc., in both the United States and Europe. Mr. Smith holds a BA in economics and history from Willamette University and an MBA in finance from Golden Gate University. Mr. Smith is a Director and Chair of the Audit Committee of publicly traded OncoGenex Pharmaceuticals Inc.

Research Interest

 finance